Trends in the prevalence of invasive fungal infections from an analysis of annual records of autopsy cases of Toho University

Mycoses

Volumn 55, Issue 5, 2012, Pages 435-443

  Shimodaira, Kayoko ^a,b   Okubo, Yoichiro ^a   Nakayama, Haruo ^a   Wakayama, Megumi ^a   Shinozaki, Minoru ^a   Ishiwatari, Takao ^a   Sasai, Daisuke ^a   Nemoto, Tetsuo ^a   Takahashi, Kei ^c   Ishii, Toshiharu ^a   Saji, Tsutomu ^b   Shibuya, Kazutoshi ^a,d  

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^d PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Autopsy; Epidemiology; Invasive fungal infection; Prevalence; Trends

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ITRACONAZOLE; MICAFUNGIN; VORICONAZOLE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPERGILLOSIS; AUTOPSY; BILE DUCT ASPERGILLOSIS; BILE DUCT CANDIDIASIS; BILE DUCT CRYPTOCOCCOSIS; BILE DUCT MUCORMYCOSIS; CANDIDIASIS; CHILD; CRYPTOCOCCOSIS; FEMALE; GASTROINTESTINAL TRACT ASPERGILLOSIS; GASTROINTESTINAL TRACT CANDIDIASIS; GASTROINTESTINAL TRACT CRYPTOCOCCOSIS; GASTROINTESTINAL TRACT MUCORMYCOSIS; HEART ASPERGILLOSIS; HEART CANDIDIASIS; HEART CRYPTOCOCCOSIS; HEART MUCORMYCOSIS; HEMATOLOGIC DISEASE; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION PREVENTION; INFECTION RISK; KIDNEY ASPERGILLOSIS; KIDNEY CANDIDIASIS; KIDNEY CRYPTOCOCCOSIS; LIVER ASPERGILLOSIS; LIVER CANDIDIASIS; LIVER MUCORMYCOSIS; LUNG ASPERGILLOSIS; LUNG MUCORMYCOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MUCORMYCOSIS; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; PULMONARY CANDIDIASIS; PULMONARY CRYPTOCOCCOSIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SYSTEMIC MYCOSIS; TREND STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AUTOPSY; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MALE; MIDDLE AGED; MYCOSES; PREVALENCE; RETROSPECTIVE STUDIES; UNIVERSITIES; YOUNG ADULT;

EID: 84865303686     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2012.02169.x     Document Type: Article

References (29)

1. Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 197-205.
2. Warnock DW. Trends in the epidemiology of invasive fungal infections. Jpn J Med Mycol 2007; 48: 1-12.
3. Groll AH, Shah PM, Mentzel C, Just-Nuebling G, Huebner K. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 1996; 33: 23-32.
4. Hotchi M, Okada M, Nasu T. Present state of fungal infections in autopsy cases in Japan. Am J Clin Pathol 1979; 74: 410-6.
5. Kanda M, Moriyama M, Ikeda M, Kojima S, Tokunaga M, Watanabe G. A statistical survey of deep mycoses in Japan, with particular reference to autopsy cases of cryptococcosis. Acta Pathol Jpn 1974; 24: 595-609.
6. Koch S, Höhne FM, Tietz HJ. Prevalence of systemic mycoses in autopsy material. Mycoses 2004; 47: 40-46.
7. Kume H, Yamazaki T, Togano T et al. Epidemiology of visceral mycoses in autopsy cases in Japan: comparison of the data from 1989, 1993, 1997, 2001, 2005 and 2007 in Annual of Pathological Autopsy Cases in Japan. Med Mycol J 2011; 52: 117-28.
8. Miyake M, Okudaira M. A statistical survey of deep fungus infection in Japan. Acta Pathol Jpn 1967; 17: 401-5.
9. Tietz HJ, Martin H, Koch S. Prevalence of endomycoses in autopsy material. Mycoses 2001; 44: 450-4.
10. Yamazaki T, Kume H, Murase S, Yamasita E, Arisawa M. Epidemiology of visceral mycoses: analysis of data in annual of the pathological autopsy cases in Japan. J Clin Microbiol 1999; 37: 1732-8.
11. Lehrnbecher T, Frank C, Engels K, Kriener S, Groll AH, Schwabe D. Trends in the postmortem epidemiology of invasive fungal infections at a university hospital. J Infect 2010; 61: 259-65.
12. Knoke M, Bernhardt H, Schwesinger G. Is there a need for autopsies in the management of fungal disease? Mycoses 2008; 51: 291-300.
13. King LS, Meehan MC. A history of the autopsy. Am J Pathol 1973; 73: 514-44.
14. Southorn PA, Narr BJ. The Massa or Rochester plastic needle. Mayo Clin Proc 2008; 83: 1165-7.
15. Joensuu H. Systemic chemotherapy for cancer: from weapon to treatment. Lancet Oncol 2008; 9: 304.
16. Hessenbruch AE. A brief history of x-rays. Endeavour 2002; 26: 137-41.
17. Linden PK. History of solid organ transplantation and organ donation. Crit Care Clin 2009; 25: 165-84.
18. Fraser JV, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992; 15: 414-21.
19. St-Germain G, Laverdière M, Pelletier R et al. Epidemiology and antifungal susceptibility of bloodstream Candida isolates in Quebec: report on 453 cases between 2003 and 2005. Can J Infect Dis Med Microbiol 2008; 19: 55-62.
20. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24, 179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309-17.
21. Algin C, Sahin A, Kiraz N, Sahintürk V, Ihtiyar E. Effectiveness of bombesin and Saccharomyces boulardii against the translocation of Candida albicans in the digestive tract in immunosuppressed rats. Surg Today 2005; 35: 869-73.
22. Koh AY, Köhler JR, Coggshall KT, Van RN, Pier GB. Mucosal damage and neutropenia are required for Candida albicans dissemination. PLoS Pathog 2008; 4: 1-10.
23. Shibuya K, Ando T, Hasegawa C et al. Pathophysiology of pulmonary aspergillosis. J Infect Chemother 2004; 10: 138-45.
24. Sugar AM. Mucormycosis. Clin Infect Dis 1992; 14: S126-9.
25. Meersseman W, Lagrou K, Spriet I et al. Significance of the isolation of Candida species from airway samples in critically ill patients: a prospective, autopsy study. Intensive Care Med 2009; 35: 1526-31.
26. Shibuya K. The latest guidelines for the diagnosis and treatment of invasive fungal infection. J Med Soc Toho Univ 2008; 55: 45-54.
27. Mineishi S, Schuening FG. Graft-versus-host disease in mini-transplant. Lymphoma 2004; 45: 1969-80.
28. Tabata N, Ohno Y, Matsui R et al. Partial cancer prevalence in Japan up to 2020: estimates based on prevalence and survival data from population-based cancer registries. Jpn J Clin Oncol 2008; 38: 146-57.
29. Mori T. Recent trends in tuberculosis, Japan. Emerg Infect Dis 2000; 6: 566-8.